Status:
UNKNOWN
The Role of Vitamin D in Predicting Response to Neoadjuvant Therapy in Patients With Rectal Cancer
Lead Sponsor:
Istanbul Training and Research Hospital
Conditions:
Rectal Cancer
Stage III Rectal Cancer
Eligibility:
All Genders
18-80 years
Brief Summary
It has been reported that better local control is achieved and sphincters are preserved at a higher rate with curative resections performed after neoadjuvant chemoradiotherapy in patients with locally...
Eligibility Criteria
Inclusion
- • All patients with locally advanced rectal cancer
Exclusion
- • below 18 years old
- patients who did not received neoadjuvant therapy
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04857203
Start Date
September 1 2020
End Date
August 31 2023
Last Update
August 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul Training and Research Hospital
Istanbul, None Selected, Turkey (Türkiye), 34098